ZimVie Inc. (NASDAQ:ZIMV) Stake Lessened by Trexquant Investment LP

Trexquant Investment LP decreased its position in shares of ZimVie Inc. (NASDAQ:ZIMV) by 43.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,212 shares of the company’s stock after selling 13,364 shares during the period. Trexquant Investment LP owned 0.06% of ZimVie worth $240,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ZIMV. Y Intercept Hong Kong Ltd acquired a new position in shares of ZimVie during the 3rd quarter valued at $528,000. Barclays PLC grew its holdings in ZimVie by 338.4% during the third quarter. Barclays PLC now owns 43,437 shares of the company’s stock worth $690,000 after acquiring an additional 33,529 shares during the period. Geode Capital Management LLC raised its position in ZimVie by 2.4% in the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company’s stock worth $10,263,000 after acquiring an additional 15,053 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in ZimVie in the 3rd quarter valued at about $275,000. Finally, JPMorgan Chase & Co. boosted its position in shares of ZimVie by 66.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company’s stock valued at $2,911,000 after purchasing an additional 73,395 shares in the last quarter. 95.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on ZIMV shares. B. Riley initiated coverage on shares of ZimVie in a research note on Thursday. They set a “buy” rating and a $16.00 target price for the company. Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Price Performance

NASDAQ ZIMV opened at $9.15 on Monday. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 1 year low of $8.56 and a 1 year high of $22.40. The company has a market cap of $254.80 million, a PE ratio of -0.70 and a beta of 2.14. The stock’s 50-day moving average price is $11.97 and its two-hundred day moving average price is $13.48.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The business had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. On average, analysts predict that ZimVie Inc. will post 0.6 EPS for the current year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.